文献速递免疫规划传染病防控与疫情报告

巴西儿童常规免疫引入四个月后C群脑膜炎球菌结合疫苗的接种影响

Impact of meningococcal C conjugate vaccination four years after introduction of routine childhood immunization in Brazil.
PubMed 文献 · Vaccine · 2017-03-18

巴西于2010年11月起为婴儿常规接种C群脑膜炎球菌结合疫苗(MCC),采用3、5月龄基础免疫加12-15月龄加强免疫,未实施补种。本研究采用生态学准实验设计,对2008至2014年国家监测与参比实验室数据库进行确定性链接,行中断时间序列分析(排除因C群疫情开展青少年补种运动的萨尔瓦多市),并与接种前预期率比较。结果显示,接种开始四年后,<12月龄婴儿MenC发病率降低67.2%(95%CI 43.0-91.4%),12-23月龄降低92.0%(77.3-106.8%),2-4岁降低64.6%(24.6-104.5%),5-9岁降低19.2%(9.5-28.9%),巴西<40岁人群共减少955例MenC病例。

要点

  • 接种四年后,<12月龄婴儿MenC发病率降低67.2%(95%CI 43.0-91.4%)。
  • 12-23月龄儿童MenC发病率降低92.0%(95%CI 77.3-106.8%)。
  • 巴西<40岁人群接种后共减少955例MenC病例。

核心结论

  • 婴儿和幼儿接种开始四年后,目标人群MenC侵袭性疾病减少。
  • 本研究为评估12-13岁即将开展的补种剂对加速巴西青少年MenC发病率下降的作用提供了稳健基线。

研究设计与样本

  • 生态学准实验设计,对2008至2014年国家通知数据库与国家参比实验室脑膜炎数据库进行确定性链接。
  • 采用中断时间序列分析,分析巴西除萨尔瓦多市以外的地区,萨尔瓦多因2010年发生C群疫情并开展青少年补种运动而仅作描述性呈现。
  • 另对圣保罗州进行时间序列分析,共分析18136例MenC病例。

主要发现

  • 最高发病率见于<12月龄婴儿,未观察到青少年第二个发病高峰。
  • 巴西<12月龄婴儿MenC发病率降低67.2%(95%CI 43.0-91.4%)。
  • 巴西12-23月龄儿童MenC发病率降低92.0%(95%CI 77.3-106.8%)。
  • 巴西2-4岁儿童MenC发病率降低64.6%(95%CI 24.6-104.5%),5-9岁儿童降低19.2%(95%CI 9.5-28.9%)。
  • 巴西<40岁人群接种后共减少955例MenC病例,圣保罗州结果与巴西整体模式一致。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Routine infant immunization with meningococcal C conjugate (MCC) vaccination started in Brazil in November 2010, scheduled at three and five months plus a booster at 12-15months of age. No catch-up was implemented. We assessed the impact of vaccination on meningococcal C disease (MenC) four years after vaccination start in the National Immunization Program. METHODS: We performed an ecological quasi-experimental design from 2008 to 2014 using a deterministic linkage between the National Notification and the National Reference Laboratory databases for meningitis. We conducted an interrupted time-series analysis considering Brazil except for Salvador municipality, because an epidemic of serogroup C disease occurred in this city, which prompted a mass vaccination campaign with catch-up for adolescents in 2010. Observed MenC rates in the post-vaccination period were compared to expected rates calculated from the pre-vaccination years. Results for Salvador were presented as descriptive data. An additional time-series analysis was performed for the state of São Paulo. RESULTS: A total of 18,136 MenC cases were analyzed. The highest incidence rates were observed for infants aged <12months and no second incident peak was observed for adolescents. For Brazil, MenC rates were reduced by 67.2% (95%CI 43.0-91.4%) for infants <12months of age, 92.0% (77.3-106.8%) for the age-group 12-23months, and 64.6% (24.6-104.5%) for children aged 2-4years. For children 5-9years old, MenC rates reduced 19.2% (9.5-28.9%). Overall, 955 MenC cases were averted in Brazil in individuals aged <40years after MCC vaccination. Results from São Paulo State, mirror the patterns seen in Brazil. CONCLUSION: After four years of infants and toddlers vaccination start, MenC invasive disease reduced in the target population. This investigation provide a robust baseline to ascertain how much the upcoming catch-up dose in 12-13years of age will accelerate the decrease in MenC incidence rates among youths in Brazil.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Andrade AL, Minamisava R, Tomich LM, et al. Impact of meningococcal C conjugate vaccination four years after introduction of routine childhood immunization in Brazil. Vaccine. 2017. PMID: 28318769. doi:10.1016/j.vaccine.2017.03.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。